Ethics Committee Makes a Statement About Leaks of Gaetz Report
Former DNC Official Keeps Bulldozing Democrat Narratives About Kamala's Loss
Meet the Child Rapist and Murderer Biden Just Took Off of Death Row
VIP Membership Christmas SALE: 60% Off!
Former Metropolitan Police Intelligence Chief Convicted of Acting As 'Double Agent' for Pr...
Key Takeaways From the House Ethics Committee Report on Matt Gaetz
Luigi Mangione Enters Plea in Shooting of UnitedHealthcare CEO
We Have the House Ethics Report on Matt Gaetz
Celebrating Media Mayhem with The Heckler Awards - Part 1: The Industry Trends...
House Dem Criticizes Biden's Decision to Commute Federal Death Sentences
Tom Homan Reveals When Trump's Mass Deportation Operation Will Begin
Trump Says the US Owning Greenland Is an 'Absolute Necessity'
Kathy Hochul's Fellow New York Officials Sure Have Something to Say About Her...
Trump Vows to Stop 'Transgender Lunacy'
Is America's Heartland the Next Stop for Vehicle-Borne Terror?
Tipsheet

Biden Administration Signs $137M Deal for Covid Test Strip Factory...But There's a Catch

AP Photo/Elaine Thompson

Amid a surge in Covid-19 cases across the country, fueled in large part by the spread of the new Omicron variant, at-home testing kits are nearly impossible to find in some areas. That makes the Biden administration’s new deal with a pharmaceutical company to increase production welcome news…except for one major catch.

Advertisement

The $137 million contract with Millipore Sigma, a unit of Germany's Merck KGaA, to build a factory for making Covid-19 test strip materials won’t be ready for at least three years, the company said, according to Fox News, doing nothing to alleviate the current demand. The move also signals the virus will not be “shut down” by any politician, as Biden vowed on the campaign trail, but will be endemic.

The money will allow the company over three years to build a new facility to produce nitrocellulose membranes, the paper that displays test results, in Sheboygan, Wisconsin. That, in turn, will allow for 85 million more tests to be produced per month, the official said. […]

The contract, which will be announced by the Department of Defense for the Department of Health and Human Services, is part of a bid by the Biden administration to ramp up production of scarce rapid COVID-19 tests, which has taken on more urgency as nations grapple with the highly infectious Omicron variant of the coronavirus. […]

But U.S. testing is behind the curve because of a lack of skilled workers, a shortage of at-home tests and under-investment in recent months, and health experts in the U.S. said Biden's latest plan was "too little, too late." (Reuters)

Advertisement

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement